Navigation Links
Are anti-poaching efforts repeating the mistakes of the 'war on drugs'?
Date:1/21/2014

Illegal poaching, fuelled by the demand for alternative 'medicines' and luxury goods in Asian markets, continues unabated. In response unprecedented levels of funding are being invested in enforcement, while events such as China's public burning of confiscated ivory, serve to publicize the problem.

However, research in Conservation Letters asks if these measures are repeating the mistakes of the 'War on Drugs' as they lack a long-term strategy to tackle the growing wealth gap between African areas of supply and Asian centers of demand, which remains a central dynamic to the problem.

The authors also show how trading bans can drive up the price of poached goods, which in turn encourages the involvement of organized criminals who operate like drug cartels.

"Much of the current narrative on responses to poaching and illegal trade in wildlife is centered on increasing enforcement efforts and anti-poaching measures. We argue that this approach risks making the same mistake as the 'war on drugs', because it doesn't address the real drivers of poaching. For example, increasing demand in East Asia and growing relative poverty nationally and internationally," said Daniel Challender from the University of Kent. "To conserve species' we need to build capacity to do so within local communities and consider supply-based approaches and demand reduction programs based on further research."


'/>"/>

Contact: Ben Norman
Sciencenewsroom@wiley.com
44-012-437-70375
Wiley
Source:Eurekalert

Page: 1

Related biology news :

1. MU researchers study of African forest elephants helps guide research efforts in the US
2. Efforts to curb climate change require greater emphasis on livestock
3. Online tool aids clinicians efforts to treat injured workers
4. 2 grants to UC Riverside boost scientists efforts in developing improved cowpea varieties
5. Leader of smoking cessation and tobacco prevention efforts receives Institute of Medicines 2013 Lienhard Award
6. "GenoVive is changing the face of personalized health by continuing research efforts with Harvard."
7. Drug design success propels efforts to fight HIV with a combination of 2 FDA-approved drugs
8. New IOM report lays out plan to determine effectiveness of obesity prevention efforts
9. Current efforts will not save the worlds most endangered cat
10. Researchers call for rethinking efforts to prevent interplanetary contamination
11. Studies support population-based efforts to lower excessive dietary sodium intakes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... DUBLIN , Feb. 16, 2017 ... the "Synthetic Biology: Global Markets" report to ... ... synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis ... DNA synthesis and assembly, genome editing, bioinformatics and specialty ...
(Date:2/16/2017)... PALM BEACH, Florida , February 16, 2017 ... vastly improving with the infusion of innovative telemedicine ... patient monitoring services that are experiencing a boom ... evolve with the advancement of technologies, services and ... Technologies Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
Breaking Biology Technology: